{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:36:20Z","timestamp":1790674580421,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":1102,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1038\/mt.2013.132","type":"journal-article","created":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T12:35:23Z","timestamp":1372163723000},"page":"1862-1875","source":"Crossref","is-referenced-by-count":26,"title":["Dose-dependent Neuroprotection of VEGF165 in Huntington's Disease Striatum"],"prefix":"10.1016","volume":"21","author":[{"given":"Stuart M","family":"Ellison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Trabalza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Tisato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Pazarentzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Papadaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despoina","family":"Goniotaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas D","family":"Mazarakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2013.132_bib1","doi-asserted-by":"crossref","unstructured":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 72 1993 971 983","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"10.1038\/mt.2013.132_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1038\/mt.2013.132_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fnana.2011.00055","article-title":"Huntington's Disease and Striatal Signaling","volume":"5","author":"Roze","year":"2011","journal-title":"Front Neuroanat"},{"key":"10.1038\/mt.2013.132_bib4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.biopha.2011.04.025","article-title":"Molecular chaperones: toward new therapeutic tools","volume":"65","author":"Almeida","year":"2011","journal-title":"Biomed Pharmacother"},{"key":"10.1038\/mt.2013.132_bib5","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1073\/pnas.100107297","article-title":"Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans","volume":"97","author":"Satyal","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2013.132_bib6","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/mt.sj.6300141","article-title":"Neuroprotection by Hsp104 and Hsp27 in lentiviral-based rat models of Huntington's disease","volume":"15","author":"Perrin","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.132_bib7","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1073\/pnas.97.4.1589","article-title":"Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins","volume":"97","author":"Krobitsch","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2013.132_bib8","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1093\/hmg\/9.13.2009","article-title":"Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity","volume":"9","author":"Jana","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2013.132_bib9","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1093\/hmg\/9.19.2811","article-title":"Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila","volume":"9","author":"Chan","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2013.132_bib10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0014-4886(03)00044-X","article-title":"Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF","volume":"181","author":"McBride","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1038\/mt.2013.132_bib11","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ymthe.2004.02.016","article-title":"AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease","volume":"9","author":"Kells","year":"2004","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.132_bib12","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/gt.2010.71","article-title":"BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington's disease","volume":"17","author":"Giralt","year":"2010","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2013.132_bib13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-4159.2007.05137.x","article-title":"Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice","volume":"105","author":"Gharami","year":"2008","journal-title":"J Neurochem"},{"key":"10.1038\/mt.2013.132_bib14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1006\/nbdi.2001.0388","article-title":"Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's disease","volume":"8","author":"de Almeida","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1038\/mt.2013.132_bib15","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1126\/science.6823562","article-title":"Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid","volume":"219","author":"Senger","year":"1983","journal-title":"Science"},{"key":"10.1038\/mt.2013.132_bib16","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0006-291X(89)92678-8","article-title":"Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells","volume":"161","author":"Ferrara","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/mt.2013.132_bib17","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1200\/JCO.2002.10.088","article-title":"Vascular permeability factor\/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy","volume":"20","author":"Dvorak","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1038\/mt.2013.132_bib18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/88842","article-title":"Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration","volume":"28","author":"Oosthuyse","year":"2001","journal-title":"Nat Genet"},{"key":"10.1038\/mt.2013.132_bib19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature02544","article-title":"VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model","volume":"429","author":"Azzouz","year":"2004","journal-title":"Nature"},{"key":"10.1038\/mt.2013.132_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nn1360","article-title":"Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS","volume":"8","author":"Storkebaum","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1038\/mt.2013.132_bib21","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/dneu.20747","article-title":"Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration","volume":"69","author":"Lunn","year":"2009","journal-title":"Dev Neurobiol"},{"key":"10.1038\/mt.2013.132_bib22","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/jgm.600","article-title":"Lentiviral vectors for treating and modeling human CNS disorders","volume":"6","author":"Azzouz","year":"2004","journal-title":"J Gene Med"},{"key":"10.1038\/mt.2013.132_bib23","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.nbd.2005.05.017","article-title":"Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment","volume":"20","author":"Zala","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1038\/mt.2013.132_bib24","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/sj.mt.6300185","article-title":"Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates","volume":"15","author":"Palfi","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.132_bib25","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1523\/JNEUROSCI.22-09-03473.2002","article-title":"Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length","volume":"22","author":"de Almeida","year":"2002","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2013.132_bib26","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/hmg\/ddr148","article-title":"Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington's disease: role on chromatin remodeling at the PGC-1-alpha promoter","volume":"20","author":"Martin","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2013.132_bib27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nbt1049","article-title":"Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters","volume":"23","author":"Amendola","year":"2005","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2013.132_bib28","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1073\/pnas.97.6.2898","article-title":"Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease","volume":"97","author":"Wyttenbach","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2013.132_bib29","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0040-8166(94)90042-6","article-title":"Phenotypic characterisation of rat striatal neurones in primary culture","volume":"26","author":"Simpson","year":"1994","journal-title":"Tissue Cell"},{"key":"10.1038\/mt.2013.132_bib30","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1093\/hmg\/ddg305","article-title":"Early and reversible neuropathology induced by tetracycline-regulated lentiviral overexpression of mutant huntingtin in rat striatum","volume":"12","author":"R\u00e9gulier","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2013.132_bib31","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/gt.2010.152","article-title":"VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson's disease","volume":"18","author":"Xiong","year":"2011","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2013.132_bib32","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.expneurol.2004.12.022","article-title":"Astrocyte growth effects of vascular endothelial growth factor (VEGF) application to perinatal neocortical explants: receptor mediation and signal transduction pathways","volume":"192","author":"Mani","year":"2005","journal-title":"Exp Neurol"},{"key":"10.1038\/mt.2013.132_bib33","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nature04481","article-title":"From angiogenesis to neuropathology","volume":"438","author":"Greenberg","year":"2005","journal-title":"Nature"},{"key":"10.1038\/mt.2013.132_bib34","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1124\/mol.107.038851","article-title":"Enhancement of glucose transporter expression of brain endothelial cells by vascular endothelial growth factor derived from glioma exposed to hypoxia","volume":"73","author":"Yeh","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1038\/mt.2013.132_bib35","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0306-4522(01)00615-7","article-title":"Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain","volume":"110","author":"Krum","year":"2002","journal-title":"Neuroscience"},{"key":"10.1038\/mt.2013.132_bib36","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/1073858405278321","article-title":"Reactive astrocytes in neural repair and protection","volume":"11","author":"Sofroniew","year":"2005","journal-title":"Neuroscientist"},{"key":"10.1038\/mt.2013.132_bib37","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1084\/jem.172.6.1535","article-title":"Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration","volume":"172","author":"Clauss","year":"1990","journal-title":"J Exp Med"},{"key":"10.1038\/mt.2013.132_bib38","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/bies.20092","article-title":"VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection","volume":"26","author":"Storkebaum","year":"2004","journal-title":"Bioessays"},{"key":"10.1038\/mt.2013.132_bib39","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1096\/fj.00-0495fje","article-title":"Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades","volume":"15","author":"Matsuzaki","year":"2001","journal-title":"FASEB J"},{"key":"10.1038\/mt.2013.132_bib40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nbd.2004.06.004","article-title":"Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration","volume":"17","author":"Van Den Bosch","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1038\/mt.2013.132_bib41","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/01.wcb.0000037988.07114.98","article-title":"Vascular endothelial growth factor protects cultured rat hippocampal neurons against hypoxic injury via an antiexcitotoxic, caspase-independent mechanism","volume":"22","author":"Svensson","year":"2002","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1038\/mt.2013.132_bib42","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0306-4522(98)00540-5","article-title":"Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures","volume":"90","author":"Silverman","year":"1999","journal-title":"Neuroscience"},{"key":"10.1038\/mt.2013.132_bib43","doi-asserted-by":"crossref","first-page":"11410","DOI":"10.1074\/jbc.M111085200","article-title":"Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system","volume":"277","author":"Ogunshola","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2013.132_bib44","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0306-4522(01)00154-3","article-title":"Caspase-3 and the regulation of hypoxic neuronal death by vascular endothelial growth factor","volume":"108","author":"Jin","year":"2001","journal-title":"Neuroscience"},{"key":"10.1038\/mt.2013.132_bib45","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1523\/JNEUROSCI.4433-06.2007","article-title":"Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice","volume":"27","author":"Wang","year":"2007","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2013.132_bib46","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neulet.2007.05.033","article-title":"Favorable effects of VEGF gene transfer on a rat model of Parkinson disease using adeno-associated viral vectors","volume":"421","author":"Tian","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1038\/mt.2013.132_bib47","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12640-009-9079-0","article-title":"Injectable hydrogels providing sustained delivery of vascular endothelial growth factor are neuroprotective in a rat model of Huntington's disease","volume":"17","author":"Emerich","year":"2010","journal-title":"Neurotox Res"},{"key":"10.1038\/mt.2013.132_bib48","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.expneurol.2003.09.002","article-title":"Long-term lentiviral-mediated expression of ciliary neurotrophic factor in the striatum of Huntington's disease transgenic mice","volume":"185","author":"Zala","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1038\/mt.2013.132_bib49","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00005072-199906000-00006","article-title":"Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain","volume":"58","author":"Proescholdt","year":"1999","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1038\/mt.2013.132_bib50","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1172\/JCI60842","article-title":"Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease","volume":"122","author":"Argaw","year":"2012","journal-title":"J Clin Invest"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616322535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616322535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T06:57:10Z","timestamp":1563260230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616322535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1525001616322535"],"URL":"https:\/\/doi.org\/10.1038\/mt.2013.132","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}